Crossmark

Novel Isoxazole Functionalized Quinazolinone Derivatives and Their Anticancer Activity

Crossref DOI link: https://doi.org/10.1134/S1070363224611128

Published Online: 2025-02-27

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Konda, S. K. https://orcid.org/0000-0002-2576-5742
Kanuri, A. K. https://orcid.org/0000-0002-1350-7148
Chennuri, B. K. https://orcid.org/0000-0002-7223-1110
Anjum, R. https://orcid.org/0000-0002-5721-1939
Trivedi, R. https://orcid.org/0000-0002-5713-0098
Patlola, M. https://orcid.org/0000-0001-8829-2041
Yamini, S. https://orcid.org/0009-0007-9707-3247
Bhoomandla, S. https://orcid.org/0000-0002-7156-5688
License Information

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-01-01
More Information

Article History

Received: 21 October 2024

Revised: 20 November 2024

Accepted: 20 November 2024

First Online: 27 February 2025

CONFLICT OF INTEREST

: The authors declare no conflict of interest.